研究者
J-GLOBAL ID：201801008846524214   更新日: 2023年09月01日

安田 庸輔

Yasuda Yosuke
所属機関・部署：
がん研有明病院 泌尿器科

がん研有明病院 泌尿器科 について


職名： 副医長
論文 (69件)：
  • Worapat Attawettayanon, Yosuke Yasuda, Jj H Zhang, Akira Kazama, Nityam Rathi, Carlos Munoz-Lopez, Kieran Lewis, Snehi Shah, Jianbo Li, João Pedro Emrich Accioly, et al. Selective Use of Neoadjuvant Targeted Therapy Is Associated with Greater Achievement of Partial Nephrectomy for High-complexity Renal Masses in a Solitary Kidney. European urology open science. 2023. 54. 1-9
  • Steven C Campbell, Yosuke Yasuda. Off-clamp partial nephrectomy: Level 1 data regarding real-world utility (or futility). BJU international. 2022. 129. 2. 131-132
  • Diego Aguilar Palacios, Rebecca A Campbell, Yosuke Yasuda, Gustavo Roversia, Carlos Munoz-Lopez, Emily Abramczyk, Maureen Kelly, Elvis R Caraballo, Chalairat Suk-Ouichai, Lin Lin, et al. Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications. Urology. 2022. 159. 139-145
  • Cathrine Keiner, Margaret Meagher, Dattatraya Patil, Kazutaka Saito, Arman Walia, Franklin Liu, Raksha Dutt, Nathan Miller, Sohail Dhanji, Ava Saidian, et al. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Frontiers in oncology. 2022. 12. 995991-995991
  • 島田 航, 木村 浩一朗, 田中 一, 福田 翔平, 安田 庸輔, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 立石 宇貴秀, et al. Radiomics解析を用いた臨床的限局性腎細胞癌におけるpT3a upstagingの予測. 日本泌尿器科学会総会. 2021. 109回. PP53-02
もっと見る
MISC (7件)：
  • Yosuke Yasuda, Yasuhisa Fujii, Takeshi Yuasa, Shinya Yamamoto, Junji Yonese, Iwao Fukui. Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?. INTERNATIONAL JOURNAL OF UROLOGY. 2015. 22. 1. 132-133
  • Yosuke Yasuda, Yasuhisa Fujii, Takeshi Yuasa, Shinichi Kitsukawa, Shinji Urakami, Shinya Yamamoto, Junji Yonese, Shunji Takahashi, Iwao Fukui. Significance of zoledronic acid on survival in patients with bone metastases from renal cell carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2013. 31. 6
  • Yasuhisa Fujii, Yosuke Yasuda, Takeshi Yuasa, Gen Sukegawa, Shinichi Kitsukawa, Shinji Urakami, Shinya Yamamoto, Junji Yonese, Shunji Takahashi, Iwao Fukui. Significance of zoledronic acid on survival in patients with bone metastases from renal cell carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2012. 30. 15
  • Yosuke Yasuda, Kazutaka Saito, Gen Sukegawa, Hajime Tanaka, Masaya Ito, Shinichi Kitsukawa, Takeshi Yuasa, Shinji Urakami, Shinya Yamamoto, Shunji Takahashi, et al. Impact of pretreatment C-reactive protein on overall survival for patients with metastatic renal cell carcinoma treated with sunitinib. JOURNAL OF CLINICAL ONCOLOGY. 2012. 30. 5
  • Yasuhisa Fujii, Mizuaki Sakura, Kazutaka Saito, Yasumasa Iimura, Yosuke Yasuda, Fumitaka Koga, Hitoshi Masuda, Satoru Kawakami, Junji Yonese, Iwao Fukui, et al. NOMOGRAM TO PREDICT MINIMAL-FAT ANGIOMYOLIPOMA AT NEPHRECTOMY FOR RENAL MASSES PRESUMED TO BE STAGE 1 RENAL CELL CARCINOMA: IMPACT OF SEX, AGE, AND TUMOR SIZE. JOURNAL OF UROLOGY. 2011. 185. 4. E277-E277
もっと見る
講演・口頭発表等 (58件)：
  • Usefulness of apparent diffusion coefficient ratio between tumor andnontumor as an imaging biomarker for prostate cancer.
    (The 114th annual meeting of the AmericanUrological Association, 2019)
  • Impact of bladder neck involvement and positive urine cytology in substratifying intermediate-risk non-muscle-invasive bladder cancer patients based on the prediction of high-risk recurrence.
    (113th annual meeting of the American Urological Association 2019)
  • Who benefits additionally from concurrent systematic biopsy at the time ofMRI-ultrasound fusion targeted biopsy to detect significant prostate cancer?
    (The 114th annual meeting of the American Urological Association 2019)
  • High levels of heat-shock factor 1 (HSF1) are associated with poor prognosisin muscle-invasive bladder cancer patients treated with chemoradiation-basedbladder sparing protocol.
    (113th annual meeting of the American Urological Association 2019)
  • 筋層浸潤膀胱癌に対する4者併用膀胱温存療法(TUR+低用量化学放射線療法+膀胱部分切除):サルコペニアを有する症例での治療成績
    (第107回日本泌尿器科学会総会 2019)
もっと見る
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM